Related Experiment Video
Updated: Jun 18, 2026
06:06
Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines?
Pierre R Smeesters1, David J McMillan, Kadaba S Sriprakash
1Bacterial Pathogenesis Laboratory, Queensland Institute of Medical Research, Brisbane, Queensland 4029, Australia. psmeeste@ulb.ac.be
Expert Review of Vaccines
|November 13, 2009
Summary
Group A Streptococcus (GAS) causes many human diseases. This review examines global epidemiology to assess the effectiveness of M protein-based vaccines against GAS infections.
Area of Science:
- Microbiology
- Immunology
- Epidemiology
Background:
- Group A Streptococcus (GAS) is a significant human bacterial pathogen.
- The GAS surface M protein is crucial for pathogenesis and a key target for vaccines.
- Understanding M protein diversity is essential for vaccine development.
Purpose of the Study:
- To review global GAS epidemiological data.
- To evaluate the theoretical efficacy of two M protein-based vaccine strategies.
- To highlight the impact of GAS epidemiology on vaccine effectiveness.
Main Methods:
- Compilation of GAS epidemiological studies from various countries.
- Analysis of M protein types prevalent in different regions.
- Modeling theoretical vaccine efficacy based on epidemiological data.
Main Results:
- Significant geographical variation exists in GAS M protein types.
- The prevalence of specific M protein types impacts vaccine coverage.
- Current vaccine strategies may have variable efficacy depending on the region.
Conclusions:
- Global GAS epidemiology is critical for designing effective M protein-based vaccines.
- Vaccine strategies must account for regional M protein diversity.
- Further research is needed to optimize GAS vaccine efficacy worldwide.
Related Concept Videos
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:27Streptococcal Pharyngitis
Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
01:20Determinants of Bacterial Pathogenicity and Virulence
Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...